Biopharma | May 13, 2026
Eli Lilly launches Lormalzi for early Alzheimer’s treatment in India
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors
Initiatives include scholarships, STEM initiatives, and healthcare capacity-building programmes supporting women and girls across 52 countries
Advanced image-free robotic platform to support greater precision, personalised planning, and improved patient outcomes
In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike
The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
Dr Reddy has made remarkable contributions towards advancing cancer care through clinical excellence, pioneering research, academic mentorship, and compassionate healing
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
Subscribe To Our Newsletter & Stay Updated
